Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
McKinsey
Mallinckrodt
Merck
Moodys

Last Updated: October 14, 2019

DrugPatentWatch Database Preview

Custopharm Inc Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for CUSTOPHARM INC, and what generic and branded alternatives to CUSTOPHARM INC drugs are available?

CUSTOPHARM INC has six approved drugs.



Summary for Custopharm Inc
US Patents:0
Tradenames:6
Ingredients:6
NDAs:6
Patent Litigation for Custopharm Inc: See patent lawsuits for Custopharm Inc

Drugs and US Patents for Custopharm Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Custopharm Inc FLUDARABINE PHOSPHATE fludarabine phosphate INJECTABLE;INJECTION 076349-001 Aug 28, 2003 AP RX No No   See Pricing   See Pricing
Custopharm Inc VALRUBICIN valrubicin SOLUTION;INTRAVESICAL 206430-001 Apr 19, 2019 AO RX No No   See Pricing   See Pricing
Custopharm Inc GANCICLOVIR SODIUM ganciclovir sodium INJECTABLE;INJECTION 212001-001 Jun 20, 2019 AP RX No No   See Pricing   See Pricing
Custopharm Inc PENTOBARBITAL SODIUM pentobarbital sodium INJECTABLE;INJECTION 203619-001 Nov 13, 2017 AP RX No No   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Colorcon
Mallinckrodt
Johnson and Johnson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.